{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,3]],"date-time":"2025-08-03T04:19:03Z","timestamp":1754194743988},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2007,10,8]],"date-time":"2007-10-08T00:00:00Z","timestamp":1191801600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ann Gen Psychiatry"],"published-print":{"date-parts":[[2007,12]]},"DOI":"10.1186\/1744-859x-6-25","type":"journal-article","created":{"date-parts":[[2007,10,9]],"date-time":"2007-10-09T06:13:30Z","timestamp":1191910410000},"source":"Crossref","is-referenced-by-count":4,"title":["Oxcarbazepine as monotherapy of acute mania in insufficiently controlled type-1 diabetes mellitus: a case-report"],"prefix":"10.1186","volume":"6","author":[{"given":"Panagiotis","family":"Oulis","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Evangelos","family":"Karapoulios","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anastasios V","family":"Kouzoupis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vasilios G","family":"Masdrakis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Konstantinos A","family":"Kontoangelos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Konstantinos","family":"Makrilakis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nikolaos A","family":"Karakatsanis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charalambos","family":"Papageorgiou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nikolaos","family":"Katsilambros","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Constantin R","family":"Soldatos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2007,10,8]]},"reference":[{"key":"582_CR1","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1080\/10401230590932380","volume":"17","author":"RS McIntyre","year":"2005","unstructured":"McIntyre RS, Konarski JZ, Misener VL, Kennedy SH: Bipolar disorder and diabetes mellitus: epidemiology, etiology, and treatment implications. Ann Clin Psychiatry. 2005, 17: 83-93. 10.1080\/10401230590932380.","journal-title":"Ann Clin Psychiatry"},{"key":"582_CR2","doi-asserted-by":"publisher","first-page":"1034","DOI":"10.4088\/JCP.v67n0704","volume":"67","author":"V Taylor","year":"2006","unstructured":"Taylor V, MacQueen G: Associations between bipolar disorder and metabolic syndrome: a review. J Clin Psychiatry. 2006, 67: 1034-1041.","journal-title":"J Clin Psychiatry"},{"key":"582_CR3","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.4088\/JCP.v67n0707","volume":"67","author":"JJ Guo","year":"2006","unstructured":"Guo JJ, Keck PE, Corey-Lisle , Li H, Jiang D, Jang R, L'Italien GJ: Risk of diabetes mellitus associated with atypical antipsychotic use among patients with bipolar disorder: A retrospective, population based, case-control study. J Clin Psychiatry. 2006, 67: 1055-1061.","journal-title":"J Clin Psychiatry"},{"key":"582_CR4","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1024\/0040-5930.62.7.481","volume":"62","author":"R Lehman","year":"2005","unstructured":"Lehman R, Pavlicek V, Spinos GA, Weber M: Islet transplantation in type-1 diabetes mellitus. Ther Umsch. 2005, 62: 481-486. 10.1024\/0040-5930.62.7.481.","journal-title":"Ther Umsch"},{"key":"582_CR5","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/0022-3956(75)90026-6","volume":"12","author":"MF Folstein","year":"1975","unstructured":"Folstein MF, Folstein SE, McHugh PR: 'Mini-mental state'. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975, 12: 189-198. 10.1016\/0022-3956(75)90026-6.","journal-title":"J Psychiatr Res"},{"key":"582_CR6","volume-title":"Diagnostic and Statistical Manual of Mental Disorders","author":"American Psychiatric Association (APA)","year":"2000","unstructured":"American Psychiatric Association (APA): Diagnostic and Statistical Manual of Mental Disorders. 2000, Washington DC: APA, 4 revised text","edition":"4 revised text"},{"key":"582_CR7","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1192\/bjp.133.5.429","volume":"133","author":"RC Young","year":"1978","unstructured":"Young RC, Biggs JT, Ziegler VE, Meyer DA: A rating scale for mania: reliability, validity and sensitivity. Br J Psychiatry. 1978, 133: 429-435.","journal-title":"Br J Psychiatry"},{"key":"582_CR8","doi-asserted-by":"publisher","DOI":"10.1176\/appi.books.9780890423370","volume-title":"APA Practice Guidelines for the Treatment of Psychiatric Disorders \u2013 Compendium","author":"American Psychiatric Association (APA)","year":"2006","unstructured":"American Psychiatric Association (APA): APA Practice Guidelines for the Treatment of Psychiatric Disorders \u2013 Compendium. 2006, Washington DC: APA"},{"key":"582_CR9","volume-title":"The Maudsley 2005\u20132006 Prescribing Guidelines","author":"D Taylor","year":"2006","unstructured":"Taylor D, Kerwin R, Paton : The Maudsley 2005\u20132006 Prescribing Guidelines. 2006, London: Taylor & Francis, 8","edition":"8"},{"issue":"3","key":"582_CR10","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1080\/10401230600801234","volume":"18","author":"K Ramaswamy","year":"2005","unstructured":"Ramaswamy K, Masand PS, Nasrallah H: Do certain atypical antipsychotics increase the risk of diabetes? A critical review of 17 pharmacoepidemiologic studies. Ann Clin Psychiatry. 2005, 18 (3): 183-194. 10.1080\/10401230600801234.","journal-title":"Ann Clin Psychiatry"},{"issue":"5 Suppl 1","key":"582_CR11","doi-asserted-by":"publisher","first-page":"S7","DOI":"10.1097\/01.jcp.0000142282.62336.e9","volume":"24","author":"HA Nasrallah","year":"2004","unstructured":"Nasrallah HA, Newcomer JW: Atypical antipsychotics and metabolic dysregulation: evaluating the risk\/benefit equation and improving the standard of care. J Clin Psychopharmacol. 2004, 24 (5 Suppl 1): S7-S14. 10.1097\/01.jcp.0000142282.62336.e9.","journal-title":"J Clin Psychopharmacol"},{"issue":"4","key":"582_CR12","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1017\/S1461145704004651","volume":"7","author":"RM Hirschfeld","year":"2004","unstructured":"Hirschfeld RM, Kasper S: A review of the evidence for carbamazepine and oxcarbazepine in the treatment of bipolar disorder. Int J Neuropsychopharmacol. 2004, 7 (4): 507-522. 10.1017\/S1461145704004651.","journal-title":"Int J Neuropsychopharmacol"},{"key":"582_CR13","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1176\/ajp.2006.163.7.1179","volume":"163","author":"KD Wagner","year":"2006","unstructured":"Wagner KD, Kowatch RA, Emslie GJ, Findling RL, Wilens TE, McCaque K: A double blind, randomized placebo-controlled trial of oxcarbazepine in the treatment of bipolar disorder in children and adolescents. Am J Psychiatry. 2006, 163: 1179-1186. 10.1176\/appi.ajp.163.7.1179.","journal-title":"Am J Psychiatry"},{"issue":"5","key":"582_CR14","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1080\/00048670701261186","volume":"41","author":"T Suppes","year":"2007","unstructured":"Suppes T, Kelly DI, Hynan LS, Snow DE, Sureddi S, Foster B, Curley E: Comparison of two anticonvulsants in a randomized, single-blind treatment of hypomanic symptoms in patients with bipolar disorder. Aust N Z J Psychiatry. 2007, 41 (5): 397-402. 10.1080\/00048670701261186.","journal-title":"Aust N Z J Psychiatry"},{"issue":"5","key":"582_CR15","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1517\/14656566.8.5.649","volume":"8","author":"M Mazza","year":"2007","unstructured":"Mazza M, Di Nikola M, Martinotti G, Taranto C, Pozzi G, Conte G, Janiri L, Bria P, Mazza S: Oxcarbazepine in bipolar disorder: a critical review of the literature. Expert Opin Pharmacother. 2007, 8 (5): 649-656. 10.1517\/14656566.8.5.649.","journal-title":"Expert Opin Pharmacother"},{"issue":"4","key":"582_CR16","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1517\/14656566.7.4.401","volume":"7","author":"PJ Goodnick","year":"2006","unstructured":"Goodnick PJ: Anticonvulsants in the treatment of bipolar mania. Expert Opin Pharmacother. 2006, 7 (4): 401-410. 10.1517\/14656566.7.4.401.","journal-title":"Expert Opin Pharmacother"},{"key":"582_CR17","doi-asserted-by":"publisher","first-page":"943","DOI":"10.4088\/JCP.v64n0813","volume":"64","author":"SN Ghaemi","year":"2003","unstructured":"Ghaemi SN, Berv DA, Klugman J, Rosenquist KJ, Hsu DJ: Oxcarbazepine treatment of bipolar disorder. J Clin Psychiatry. 2003, 64: 943-945.","journal-title":"J Clin Psychiatry"},{"key":"582_CR18","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/S0165-0327(02)00407-X","volume":"79","author":"A Benedetti","year":"2004","unstructured":"Benedetti A, Lattanzi L, Pini S, Musetti L, Dell'Osso L, Cassano GB: Oxcarbazepine as add-on treatment in patients with bipolar manic, mixed or depressive episode. J Affect Dis. 2004, 79: 273-277. 10.1016\/S0165-0327(02)00407-X.","journal-title":"J Affect Dis"},{"key":"582_CR19","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1177\/070674370605100809","volume":"51","author":"W Pratoomsri","year":"2006","unstructured":"Pratoomsri W, Yatham LN, Bond DJ, Lam RW, Sohn C: Oxcarbazepine in the treatment of bipolar disorder: a review. Can J Psychiatry. 2006, 51: 540-545.","journal-title":"Can J Psychiatry"},{"key":"582_CR20","doi-asserted-by":"publisher","first-page":"5","DOI":"10.4088\/JCP.v64n0301","volume":"64","author":"HS White","year":"2003","unstructured":"White HS: Mechanism of action of newer anticonvulsants. J Clin Psychiatry. 2003, 64: 5-8.","journal-title":"J Clin Psychiatry"},{"key":"582_CR21","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1111\/j.1399-5618.2005.00235.x","volume":"7","author":"DL Dunner","year":"2005","unstructured":"Dunner DL: Safety and tolerability of emerging pharmacological treatments for bipolar disorder. Bipolar Disord. 2005, 7: 307-325. 10.1111\/j.1399-5618.2005.00235.x.","journal-title":"Bipolar Disord"}],"container-title":["Annals of General Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1744-859X-6-25.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1744-859X-6-25\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1744-859X-6-25.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,1,22]],"date-time":"2019-01-22T16:48:06Z","timestamp":1548175686000},"score":1,"resource":{"primary":{"URL":"https:\/\/annals-general-psychiatry.biomedcentral.com\/articles\/10.1186\/1744-859X-6-25"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,10,8]]},"references-count":21,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2007,12]]}},"alternative-id":["582"],"URL":"https:\/\/doi.org\/10.1186\/1744-859x-6-25","relation":{},"ISSN":["1744-859X"],"issn-type":[{"value":"1744-859X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,10,8]]},"article-number":"25"}}